Compounds > imiquimod
Page last updated: 2024-08-24

imiquimod and Cancer of Mouth

imiquimod has been researched along with Cancer of Mouth in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, B; Jing, D; Lam, KS; Li, JJ; Li, Y; Sun, Y; Wang, L; Yang, F; Zhang, L1
Chrisovergis, A; Eleftheriadou, A; Ferekidou, E; Gkoulioni, V; Kandiloros, D; Lazaris, ACh; Yiotakis, I1
Bogatch, K; Carvajal, RD; Chapman, PB; Chi, DS; Costantino, PD; Flavin, M; Gardner, GJ; Pulitzer, MP; Schwartz, GK; Smyth, EC; Wolchok, JD1
Ahn, MY; Ahn, SG; Cheong, HH; Kwon, SM; Lee, J; Min, SK; Park, JH; Yoon, JH1
de C Monteiro, JS; de Oliveira, SC; de Souza, SC; dos Santos, JN; Gurgel, CA; Pinheiro, AL; Reis Júnior, JA1
Barten, M; Gross, G; Gundlach, KK; Saka, B; Wenzel, K; Zimmermann, R1
Bug, R; Gille, J; Kaufmann, R; Kovács, A; Spieth, K; Wolter, M1

Other Studies

7 other study(ies) available for imiquimod and Cancer of Mouth

ArticleYear
Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer.
    Nano letters, 2018, 11-14, Volume: 18, Issue:11

    Topics: Animals; Cell Line, Tumor; Drug Carriers; Female; Heterografts; Humans; Imiquimod; Immunologic Factors; Isografts; Mammary Neoplasms, Animal; Mice; Mouth Neoplasms; Nanoparticles; Photochemotherapy; Xenograft Model Antitumor Assays

2018
The efficacy of imiquimod on dysplastic lesions of the oral mucosa: an experimental model.
    Anticancer research, 2010, Volume: 30, Issue:7

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Imiquimod; Male; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Rats; Rats, Wistar

2010
Treatment of locally recurrent mucosal melanoma with topical imiquimod.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-20, Volume: 29, Issue:33

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms

2011
Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2012, Volume: 41, Issue:7

    Topics: Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Humans; Imiquimod; Mouth Neoplasms; Necrosis; Toll-Like Receptor 7; Tumor Cells, Cultured

2012
Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.
    Lasers in medical science, 2013, Volume: 28, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cheek; Combined Modality Therapy; Cricetinae; Imiquimod; Low-Level Light Therapy; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms

2013
Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod.
    Medical microbiology and immunology, 2003, Volume: 192, Issue:3

    Topics: Aminoquinolines; Carcinoma, Squamous Cell; Electrosurgery; Female; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Middle Aged; Mouth Neoplasms; Papilloma

2003
Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa.
    The Lancet. Oncology, 2006, Volume: 7, Issue:12

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Melanoma; Mouth Mucosa; Mouth Neoplasms; Skin Neoplasms

2006